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ABSTRACT 
 
Molecular imaging is a newly emerging field in which the modern tools of molecular and cell biology have been 
married to state-of-the-art technologies for noninvasive imaging. The study of molecular imaging will lead to better 
methods for understanding biological processes as well as diagnosing and managing disease. Here we present 
noninvasive in vivo spectroscopic photoacoustic tomography (PAT)-based molecular imaging of αvβ3 integrin in a 
nude mouse U87 brain tumor. PAT combines high optical absorption contrast and high ultrasonic resolution by 
employing short laser pulses to generate acoustic waves in biological tissues through thermoelastic expansion. 
Spectroscopic PAT-based molecular imaging offers the separation of the contributions from different absorbers based 
on the differences in optical absorption spectra among those absorbers. In our case, in the near infrared (NIR) range, 
oxy-heamoglobin (O2Hb), deoxy-heamoglobin (HHb) and the injected αvβ3–targeted peptide-ICG conjugated NIR 
fluorescent contrast agent are the three main absorbers. Therefore, with the excitation by multiple wavelength laser 
pulses, spectroscopic PAT-based molecular imaging not only provides the level of the contrast agent accumulation in 
the U87 glioblastoma tumor, which is related to the metabolism and angiogenesis of the tumor, but also offers the 
information on tumor angiogenesis and tumor hypoxia. 
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1. INTRODUCTION 
 
The development of noninvasive in vivo molecular imaging techniques has been an area of great clinical interest. 
Initially driven by in situ reporter imaging technology, the study of molecular imaging should lead to better methods for 
studying biological processes as well as diagnosing and managing disease. The three common noninvasive molecular 
imaging technologies that have been developed more-or-less in parallel, are: (a) MR imaging;1 (b) nuclear imaging 
(quantitative autoradiography, gamma camera and PET),2 and (c) in vivo optical imaging of small animals.3 A 
comprehensive review of these techniques is beyond the scope of this paper, but excellent reviews can be found in the 
literature. 4 Among these technologies, in vivo optical imaging faces the greatest challenge, which is the highly 
scattering nature of the biological tissues that significantly degrades the resolution. Photoacoustic tomography (PAT) is 
an emerging imaging modality that overcomes the scattering drawback and takes advantage of the merits and most 
compelling features of both optics and ultrasound, providing both high optical contrast and good ultrasound resolution.5 
PA signals are induced by pulsed laser illumination. When laser energy is absorbed by biological tissues, the resulting 
thermal expansion of the tissues generates ultrasonic waves. The ultrasonic waves can be detected by an ultrasonic 
transducer and then used to reconstruct the optical absorption distribution inside the tissues. PAT has been shown to be 
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a promising tool for biomedical applications, such as the monitoring of oxygenation in blood vessels, epidermal melanin 
measurement, angiography, and breast tumor detection.6  
 
Here we present a noninvasive in vivo spectroscopic PAT-based molecular imaging technology. Our current in vivo 
molecular imaging strategy involves the coupling of a αvβ3 integrin with a complimentary integrin αvβ3–targeted 
peptide–ICG conjugated NIR fluorescent contrast agent.7 The αvβ3–targeted peptide–ICG conjugated NIR fluorescent 
contrast agent was systematically administrated through the tail vein into the nude mice which had been implanted with 
a U87 glioma tumor within the brain. Imaging the level of contrast agent uptake provides direct information related to 
the metabolism and angiogenesis of the tumor. Spectroscopic PAT-based molecular imaging, which is based on the 
differences in the optical absorption spectra among the oxyhemoglobin (O2Hb), deoxyhemoglobin (HHb) and the 
contrast agent, can be used to image not only the contrast agent uptake but also the total hemoglobin concentration 
(HbT) and tumor hypoxia.  
 
2. MATERIALS AND METHODS 
2.1 Animal Protocols  
All of the performed experimental animal procedures on the nude mice were approved by the University 
Laboratory Animal Care Committee of Texas A&M University and followed the guidelines of the United States 
National Institutes of Health (Guide for the Care and Use of Laboratory Animals, NIH Publication No. 86-23, revised 
1985. US Government Printing Office, Washington DC). 
 
U87 glioblastoma tumour cells were used for implantation into young adult immunocompromised nude mice 
(Harlan, Co.). The cell line is maintained in Dulbecco's Modified Eagle Medium (DMEM) with 10000 Units/ml 
Penicillin and 10% Fetal Bovine Serum (Gibco, Inc.). Stereotactic implantation of the U87 glioblastoma tumour cells 
was performed on the nude mice, which weighted about 20 grams, under full anaesthesia using a mixture of ketamine, 
87 mg/kg (Ketaset, Forth Dodge Animal Health) and xylazine, 13 mg/kg (AnaSed, Lloyd Laboratories). The cells 
(1x106) were inoculated intracranially into the caudate nucleus at a 3mm depth from the mouse head surface with a 
volume of 7 µl by using a 10 µl Hamilton syringe.8  
 
The molecular contrast agent was intravenously administrated into the nude mice through the tail vein. In vivo 
fluorescence and PAT images were acquired 20 hours after the injection. The nude mouse body temperature was 
controlled at 37°C using a water heating pad. The health status, pulse rate and the global arterial blood oxygenation of 
the mouse were monitored through the entire spectroscopic photoacoustic tomography experiment using a pulse 
oximeter (Model 8600, Nonin Medical, Inc.) with a detector clamped on the right back paw of the nude mouse. After 
the experiments, the mice were sacrificed to obtain brain tissue sections/slides. One third of the slides were imaged 
using an Odyssey fluorescence microscanner at 800 nm to verify the uptake of the molecular contrast agent. After the 
other two thirds of the slides were fixed, half of them were stained with Thionine to identify the tumor, and the other 
half were stained with anti-von Willebrand Factor viii antibody to demonstrate the tumor-associated neovascularization. 
2.1 Spectroscopic photoacoustic tomography experimental setup  
The experimental setup for the in vivo spectroscopic photoacoustic tomography of a nude mouse head is shown 
in Fig. 1. A tuneable Ti:Sa nanosecond pulse laser (LT–2211A, Lotis T II, Minsk, Belarus) pumped by an Nd:YAG 
laser (LS–2137/2, Lotis T II, Minsk, Belarus) was employed to provide multiple-wavelength laser pulses with a pulse 
repetition rate of 10 Hz. The laser beam was expanded by a concave lens, homogenized by a light diffuser, and then 
delivered to the animal head. The incident energy density of the laser beam on the surface of the mouse head was 
controlled at ~ 20mJ/cm2 (within the ANSI standard). The laser energy of each single laser was monitored and recorded 
using a photodiode (PD), and then the recorded PD signals were used for compensation of the laser energy fluctuations. 
In this project, two types of ultrasonic transducers (V323/2.25MHz, XMS-310/10MHz, Panametrics) were used as 
detectors to receive the induced acoustic signals. The diameters of the active areas are 6 mm for the 2.25 MHz 
transducer and 2 mm for the 10 MHz transducer. The nominal bandwidths for the 2.25 MHz and 10 MHz transducers 
are 66% and 80%, respectively.  
 
A computer controlled step motor drove the 2.25 MHz transducer to circularly scan the nude mouse brain at a 
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depth of ~3mm below the scalp surface with a scanning radius of 4.5 cm (note that the depth of the 2.25 MHz 
transducer is the depth of the tumor inoculation). On the other hand, the 10 MHz transducer was driven to circularly 
scan at a depth similar to that of the scalp surface with a scanning radius of 3.5 cm for acquiring the structural imaging 
of the brain cortex. The scanning step size used here is 3 degrees. The mouse was fixed by a homemade restraining 
mount with its head protruding into the water tank through a hole in the bottom. The hole was sealed with a piece of 
polyethylene membrane. The mouse head surface was covered with a thin layer of ultrasonic coupling gel. The detected 
photoacoustic signals were amplified and then digitized by an oscilloscope. The digitized signals were transferred to a 
computer, and the distribution of the optical absorption in the imaging plane (x-y plane) was reconstructed using a 
modified back-projection algorithm after a full view scanning. For spectroscopic PAT, the wavelengths were changed at 
each scanning step. Note that four wavelengths, 764nm, 784nm, 804nm and 824nm, were used in this study. 
2.2 Spectroscopic photoacoustic molecular imaging and oxygen saturation imaging  
 The spectroscopic PAT offers the opportunity to separate the contributions from different absorbers based on 
the differences in the optical absorption spectra among the absorbers. With the administration of the NIR molecular 
contrast agent, we can assume that there are only three main absorbers (the contrast agent, HHb and O2Hb) in the 
imaged brain tissue in the NIR range. Therefore, the tissue absorption coefficient at wavelength λi  can be calculated 
as 
],)[(]HbO)[(]HHb)[()( entContrastAg2HbOHHb 2 entContrastAgkkk iiiia λελελελµ ++=                 (1) 
where εHHb(λi), εO2Hb(λi)  andεContrastAgent (λi) are the known molar extinction coefficients of HHb, O2Hb and the 
contrast agent at wavelength iλ , respectively; 9  HHb[ ] ,  O2Hb[ ]  and [ContrastAgent]  are the molar 
concentrations of hemoglobin, oxy-hemoglobin and the molecular contrast agent, respectively. Since the reconstructed 
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Figure 1. Experimental setup of in vivo spectroscopic PAT for nude mouse brain imaging. 
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photoacoustic image )( iPA λ  is proportional to the absorption coefficient after being normalized by the estimated 
tissue’s optical wavelength-dependent attenuation and the incident laser fluence, the )( ia λµ  in Equation (1) can be 
replaced by )( iPA λ . Using multiple wavelength measurements and known molar extinction coefficients, point-by-
point concentration distributions of the molecular contrast agent, HHb and O2Hb can be estimated by solving the set of 
linear equations from (1) using standard linear least-squares methods. Using estimated concentrations of HHb and 
O2Hb, a point-by-point blood oxygen saturation (SO2) image can be calculated according to the following equation:  
SO2 = O2Hb[ ]O2Hb[ ]+ HHb[ ]                                                                        (2)              
 
3. RESULTS  
 
Fig. 2(A) shows a photograph of a nude mouse brain with a U87 glioblastoma tumor, in which the tumor foci 
can be seen at the right side of the brain.  Figs. 2 (B) is a Thionine stained horizontal section photo of the nude mouse 
brain with a U87 tumor at a depth of ~2mm from the brain cortex. This histological staining section shows the U87 
glioblastoma tumor located at a depth of ~2mm from the brain cortex. The integrin αvβ3–targeted peptide–ICG 
conjugated NIR fluorescent contrast agent was injected intravenously through the nude mice tail 24 hours before the 
spectroscopic PAT imaging. The contrast agent bonded to the αvβ3 integrin which is over-expressed by newly formed 
tumor microvessels. An In vivo fluorescent image (Fig. 2 (C)) was acquired on the same nude mouse before the PAT 
experiments to verify the molecular contrast agent uptake and compare with the spectroscopic PAT images. The 
fluorescence image in Fig. 2 (C) indicates the uptake of the contrast agent in the mouse brain. Fig. 2 (D) is the 
fluorescence frozen section image of the brain acquired by the Odyssey fluorescence microscanner, which further 
verifies the uptake of the contrast agent and the depth of the U87 tumor. Fig. 2 (E) shows spectroscopic PAT based 
molecular imaging showing the contrast agent distribution in the brain. In Fig. 2(E), it is clearly shown that the contrast 
agent is mainly accumulated at the tumor foci. Since PAT overcomes the resolution disadvantage of optical imaging 
that is due to the overwhelming light scattering in biological tissue, the resolution of the PAT image (Fig. 2 (E)) is 
higher than the planar fluorescence image (Fig. 2(C)). Hence, with the help of the molecular contrast agent, the tumor 
position is more precisely localized in Fig. 2 (E) than that in Fig. 2(C). In addition, tumor hypoxia, which is an 
important parameter in tumor therapy, was also imaged by the spectroscopic PAT, as shown in the blood oxygenation 
image in Fig. 2 (F).. Obviously, the level of blood oxgen saturation in the tumor foci is lower than that in the normal 
brain tissue. From Fig. 2, we can conclude that spectroscopic PAT can assess point-by-point functional parameters and 
changes in tumor areas in the brain quantitatively with high spatial resolution and, therefore, will provide better 
understanding of tumor biology and possible treatment. 
 
4. CONCLUSION  
 
The results which we presented here demonstrate that spectroscopic PAT-based molecular imaging of αvβ3 
integrin was successfully achieved by using the αvβ3-targeted NIR contrast agent. According to the relative contrast 
agent concentrations measured by spectroscopic PAT and the total injection dosage, we can quantify relatively the 
corresponding αvβ3 integrin distribution inside the nude mouse brain. This will improve our understanding of tumor 
angiogenesis at the cellular level since αvβ3 integrin is responsible for facilitating the spread of new blood vessels. 
Eventually these insights will lead to better understanding of tumor biology and new approaches for tumor therapy. In 
the meantime, tumor hypoxia imaging can also be provided by the spectroscopic PAT. Tumor hypoxia is very important 
in tumor biology and therapy. Hypoxia stimulates the tumor cells' production of acids; the hypoxia and acidity of 
tumors have important consequences for anti-tumor therapy and can contribute to the progression of tumors to a more 
aggressive metastatic phenotype.10, 11, 12 In theory, any type of pathological reaction can be monitored at the cellular 
level by spectroscopic PAT-based molecular imaging if the proper spectroscopic PAT targeting contrast agents for the 
chemicals responsible for the reaction can be employed. In the near future, spectroscopic PAT will play an important 
role in molecular imaging in tumor-related researches.  
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Figure 2. (A) Photography of a nude mouse brain with U87 glioblastoma tumor; (B) Thionine stained horizontal section 
photo of the nude mouse brain with U87 tumor; (C) Fluorescence image of the nude mouse head superimposed on the 
planar image; (D) Fluorescence frozen section image of the brain acquired by Odyssey fluorescence microscanner; (E) 
Estimated distribution of the molecular contrast agent in the brain superimposed on the photoacoustic brain structure 
image; (F) Blood oxygen saturation image of nude mice brain with U87 tumor; Both (E) and (F) are acquired by 
noninvasive in vivo spectroscopic PAT; (B) and (D) are at the depth of ~2 mm from the brain cortex; the dotted area 
indicates the tumor position. 
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